These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3434236)

  • 1. Ocular hypertension. A prospective twenty-year follow-up study.
    Lundberg L; Wettrell K; Linnér E
    Acta Ophthalmol (Copenh); 1987 Dec; 65(6):705-8. PubMed ID: 3434236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of glaucoma. II. The value of the initial examination in ocular hypertension.
    Odberg T; Riise D
    Acta Ophthalmol (Copenh); 1987 Feb; 65(1):58-62. PubMed ID: 3577706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension.
    Bengtsson B; Heijl A
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):513-8. PubMed ID: 15756577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development.
    Tezel G; Dorr D; Kolker AE; Wax MB; Kass MA
    Ophthalmology; 2000 Jun; 107(6):1194-9. PubMed ID: 10857843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for follow-up examinations in patients with ocular hypertension].
    Töteberg-Harms M; Hirn C; Funk J
    Ophthalmologe; 2011 Nov; 108(11):1016, 1018-22. PubMed ID: 22090088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular response analyser to assess hysteresis and corneal resistance factor in low tension, open angle glaucoma and ocular hypertension.
    Shah S; Laiquzzaman M; Mantry S; Cunliffe I
    Clin Exp Ophthalmol; 2008 Aug; 36(6):508-13. PubMed ID: 18954311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glaucoma diagnostics and corneal thickness].
    von Eicken J; Kohlhaas M; Höh H
    Ophthalmologe; 2005 Sep; 102(9):840-8. PubMed ID: 16132991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Precision of Hodapp-Parrish-Anderson Criteria for Staging Early Glaucomatous Damage in an Ocular Hypertension Cohort: A Retrospective Study.
    Chakravarti T
    Asia Pac J Ophthalmol (Phila); 2017; 6(1):21-27. PubMed ID: 28161915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dynamic contour tonometry with Goldmann applanation tonometry in glaucoma practice.
    Halkiadakis I; Patsea E; Chatzimichali K; Skouriotis S; Chalkidou S; Amariotakis G; Papakonstadinou D; Theodossiadis G; Amariotakis A; Georgopoulos G
    Acta Ophthalmol; 2009 May; 87(3):323-8. PubMed ID: 18631335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute intraocular pressure elevation on the minimum rim width in normal, ocular hypertensive and glaucoma eyes.
    Sharma S; Tun TA; Baskaran M; Atalay E; Thakku SG; Liang Z; Milea D; Strouthidis NG; Aung T; Girard MJ
    Br J Ophthalmol; 2018 Jan; 102(1):131-135. PubMed ID: 28490427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between measurement method and corneal structure on apparent intraocular pressure in glaucoma and ocular hypertension.
    Nessim M; Mollan SP; Wolffsohn JS; Laiquzzaman M; Sivakumar S; Hartley S; Shah S
    Cont Lens Anterior Eye; 2013 Apr; 36(2):57-61. PubMed ID: 23253796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tonometry in change. From indentation and applanation to contour adaptation].
    Kanngiesser H; Kniestedt C
    Ophthalmologe; 2005 Sep; 102(9):849-55. PubMed ID: 16132995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management outcomes of childhood glaucoma suspects.
    Greenberg MB; Osigian CJ; Cavuoto KM; Chang TC
    PLoS One; 2017; 12(9):e0185546. PubMed ID: 28945815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Booster test in the diagnosis of glaucoma].
    Bruck C; Kaltschmidt G
    Klin Oczna; 1989 Jun; 91(6):154-5. PubMed ID: 2632975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of ocular hypertension].
    Sun YY; Chen WW; Wang NL
    Zhonghua Yan Ke Za Zhi; 2016 Jul; 52(7):542-6. PubMed ID: 27531115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.
    Tanito M; Itai N; Dong J; Ohira A; Chihara E
    Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk calculation variability over time in ocular hypertensive subjects.
    Song C; De Moraes CG; Forchheimer I; Prata TS; Ritch R; Liebmann JM
    J Glaucoma; 2014 Jan; 23(1):1-4. PubMed ID: 22668983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety.
    Kuwayama Y; Nomura A
    Adv Ther; 2014 Apr; 31(4):461-71. PubMed ID: 24615289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we overestimating intraocular pressure in overweight patients?
    Aggarwal K; Sherwin JC; Zia R
    Clin Exp Ophthalmol; 2018 Apr; 46(3):303-305. PubMed ID: 28763832
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of rebound and applanation tonometry in the management of patients treated for glaucoma or ocular hypertension.
    Rehnman JB; Martin L
    Ophthalmic Physiol Opt; 2008 Jul; 28(4):382-6. PubMed ID: 18565094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.